[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gilead Sciences Inc (GILD)

Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 171,287,376
  • Shares Outstanding, K 1,239,955
  • Annual Sales, $ 29,443 M
  • Annual Income, $ 8,510 M
  • EBIT $ -2,498 M
  • EBITDA $ 262 M
  • 60-Month Beta 0.32
  • Price/Sales 5.72
  • Price/Cash Flow 12.97
  • Price/Book 14.35

Options Overview Details

View History
  • Implied Volatility 27.62% (+0.57%)
  • Historical Volatility 31.93%
  • IV Percentile 27%
  • IV Rank 32.82%
  • IV High 40.29% on 10/13/25
  • IV Low 21.43% on 12/10/25
  • Expected Move (DTE 7) 1.73 (1.25%)
  • Put/Call Vol Ratio 0.39
  • Today's Volume 6,570
  • Volume Avg (30-Day) 8,012
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 162,952
  • Open Int (30-Day) 173,200
  • Expected Range 136.41 to 139.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $2.14
  • Number of Estimates 6
  • High Estimate $2.30
  • Low Estimate $1.84
  • Prior Year $2.47
  • Growth Rate Est. (year over year) -13.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
127.61 +8.25%
on 07/23/26
140.61 -1.76%
on 07/17/26
+6.74 (+5.13%)
since 07/13/26
3-Month
121.39 +13.80%
on 06/10/26
140.61 -1.76%
on 07/17/26
+5.09 (+3.83%)
since 05/13/26
52-Week
108.46 +27.36%
on 10/02/25
157.29 -12.17%
on 02/11/26
+18.00 (+14.98%)
since 08/13/25

Most Recent Stories

More News
Gilead Sciences (GILD): Buy, Sell, or Hold Post Q2 Earnings?

Gilead Sciences (GILD): Buy, Sell, or Hold Post Q2 Earnings?

GILD : 138.14 (+1.67%)
5 Must-Read Analyst Questions From Gilead Sciences’s Q2 Earnings Call

5 Must-Read Analyst Questions From Gilead Sciences’s Q2 Earnings Call

GILD : 138.14 (+1.67%)
3 Healthcare Stocks with Open Questions

3 Healthcare Stocks with Open Questions

MYGN : 3.17 (-1.86%)
GILD : 138.14 (+1.67%)
SHC : 19.02 (+0.69%)
GILD Q2 Deep Dive: Pipeline Expansion and HIV Portfolio Drive Growth Amid Margin Pressure

GILD Q2 Deep Dive: Pipeline Expansion and HIV Portfolio Drive Growth Amid Margin Pressure

GILD : 138.14 (+1.67%)
Gilead Sciences (NASDAQ:GILD) Beats Expectations in Strong Q2 CY2026

Gilead Sciences (NASDAQ:GILD) Beats Expectations in Strong Q2 CY2026

GILD : 138.14 (+1.67%)
Gilead: Q2 Earnings Snapshot

Gilead: Q2 Earnings Snapshot

GILD : 138.14 (+1.67%)
Gilead Sciences Announces Second Quarter 2026 Financial Results

Product Sales Excluding Veklury Increased 10% Year-Over-Year to $7.6 billion Biktarvy Sales Increased 7% Year-Over-Year to $3.8 billion ...

GILD : 138.14 (+1.67%)
Shareholder Alert: Robbins LLP Informs Shareholders of the iTonic Holdings Ltd. (ITOC)– Previously Known as Pheton Holdings Ltd. (PTHL)– Class Action Lawsuit

Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Pheton Holdings Ltd (NASDAQ: PTHL) (n/k/a...

GILD : 138.14 (+1.67%)
ITOC : 0.2905 (-5.68%)
PTHL : 0.9023 (+105.16%)
Stocks Set to Open Higher as Oil Sinks on U.S.-Iran Deal Hopes, Jobs Data and Earnings Awaited

September S&P 500 E-Mini futures (ESU26) are up +0.57%, and September Nasdaq 100 E-Mini futures (NQU26) are up +0.47% this morning, pointing to a higher open on Wall Street as oil prices sank after U.S....

GOOGL : 346.36 (+0.82%)
UAL : 126.35 (+0.98%)
AAPL : 305.26 (+1.00%)
SNDK : 1,528.11 (+13.67%)
NQU26 : 30,264.25 (+0.25%)
PFE : 26.80 (+1.86%)
SHOP : 158.53 (+5.40%)
MSFT : 496.88 (+0.90%)
TSLA : 339.96 (+3.80%)
FERG : 248.12 (+1.20%)
WDC : 487.29 (+7.31%)
ESU26 : 7,830.00 (+0.10%)
Gilead Sciences (GILD) Q2 Earnings Report Preview: What To Look For

Gilead Sciences (GILD) Q2 Earnings Report Preview: What To Look For

GILD : 138.14 (+1.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya,...

See More

Key Turning Points

3rd Resistance Point 141.22
2nd Resistance Point 139.76
1st Resistance Point 138.95
Last Price 138.14
1st Support Level 136.68
2nd Support Level 135.22
3rd Support Level 134.41

See More

52-Week High 157.29
Fibonacci 61.8% 138.64
Last Price 138.14
Fibonacci 50% 132.88
Fibonacci 38.2% 127.11
52-Week Low 108.46

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.